A former Navy SEAL who used psychedelic drugs to overcome severe PTSD hopes new opportunities for research and treatment can ...

Toronto, Ontario--(Newsfile Corp. - May 13, 2026) - mPath Therapeutics Corp. ("mPath"), a pharmaceutical and medical platform company developing regulated infrastructure for ibogaine-based therapies, ...

New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicinesSilo ...

Ibogaine is getting an accelerated federal research push, but the drug is unapproved and understudied and carries a ...

Interest in the psychedelic is gaining traction. Dr. Peter Grinspoon joined GBH’s All Things Considered to discuss the drug ...

Traumatic brain injury is associated with a significantly increased longitudinal risk for mental health conditions, highlighting the need for early and continuous psychological screening to inform ...

Neurova Labs began the way many veteran-founded health technologies do, with frustration, loss and a growing belief that the systems designed to help were not addressing the full scope of the problem.

It has been known for some time that the human-animal bond is a mutually beneficial and dynamic relationship that positively influences the health and well-being of both. Lately, as the field of ...

The National Academies of Sciences, Engineering, and Medicine’s Forum on Traumatic Brain Injury convenes leaders across TBI ...